Glenmark Pharmaceuticals informs about Financial Results

20 Jul 2015 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on July 30, 2015 to consider and approve the Company’s Unaudited Financial Statements for the First Quarter ended June 30, 2015 (Q1). Further, as per the ‘Code of Conduct for Prevention of Insider Trading’ of the Company, the trading window closed for Directors and other designated employees of the Company on June 23, 2015 and will remain closed up to August 02, 2015 for the purpose of approval of Unaudited Financial Statements for the First Quarter ended June 30, 2015.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2036.00 6.40 (0.32%)
31-Dec-2025 15:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1272.00
Cipla 1507.30
Zydus Lifesciences 912.75
Lupin 2104.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×